RxDoctor Payments Data

John Willis, MD

Otolaryngology · Winston Salem, NCNPI 1982929741

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Optinose US, Inc. at 38.8% of the total. Reporting peaked in 2023 at $172 and has fallen 57.4% since, to $73 in 2025. That places this record below the midpoint for otolaryngology clinicians in NC, where the typical reported total is $856.

$551in general payments, 2019–2025

Across 23 payments — averaging $23.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$214
  • Masimo Corporation$96
  • Sanofi$46
  • GSK$40
  • Regeneron Healthcare Solutions, Inc.$37
  • Aerin Medical Inc.$32
  • plus $87 from 4 others
$9,751in research payments, 2019–2025

Across 4 payments — averaging $2437.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$10K

What the payments were for

  • Food & beverage$551100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$551 in reported general payments places this provider in the 35th percentile of 362 otolaryngology providers in North Carolina.

See all otolaryngology providers in North Carolina

Medicare billing

Part B allowed, 2024
$45,649
Medicare patients
179
Services billed
433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide43$1,181
Fluticasone Propionate75$1,127
Azelastine Hcl52$864
Ofloxacin19$782
Mupirocin34$549
Doxycycline Hyclate30$355
Triamcinolone Acetonide14$324
Montelukast Sodium69$304
Methylprednisolone24$145
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$130
Fluconazole11$107
Omeprazole17$101

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →